As the European Union (EU) moves forward with its regulatory framework for New Genomic Techniques (NGTs), the upcoming trilogue negotiations are expected to focus on the traceability and labelling of NGT1 products. This topic is particularly contentious due to its implications for various stakeholders in the agri-food value chain.
The core of the debate lies in the differentiation between conventional-like NGT plants (Category 1) and genetically modified organisms (GMOs). The European Commission’s proposal aims to distinguish NGT plants that are equivalent to conventional plant varieties from transgenic products, which are subject to stricter GMO regulations. However, there are significant concerns about the potential introduction of mandatory traceability and labelling requirements for these Category 1 NGT plants and products.
The joint position paper from 27 EU agri-food value chain partners representing millions of farmers and thousands of agri-food businesses outlines several key points:
Support for Freedom of Choice: The partners support the Commission and Council proposal that allows breeders, farmers, supply chain operators, and consumers to choose whether to use NGTs.
Rejection of Mandatory Traceability and Labelling: Mandatory traceability and labelling requirements would create unjustified costs, enforcement challenges, and trade disruptions.
Public Understanding and Informed Consumer Base: Increasing public understanding of NGTs and their benefits is crucial for fostering an informed and engaged consumer base.
“We reiterate our call for a science-based and proportionate legal framework to strengthen the competitiveness and resilience of the European agricultural and food supply systems”, says Garlich von Essen, Secretary General of Euroseeds. ”A rapid adoption of a fit-for-purpose NGT regulation will ensure a level playing field with third countries and safeguard free trade between the EU and its global partners.”
